Cargando…

Effect of teriparatide (rh-PTH 1–34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: A retrospective comparative study

BACKGROUND: Teriparatide (recombinant human parathyroid hormone 1–34) is increasingly used for the treatment of severe osteoporosis because it stimulates bone formation and may potentially enhance fracture healing. The objective of this study was to investigate the effects of teriparatide versus a b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwata, Akira, Kanayama, Masahiro, Oha, Fumihiro, Hashimoto, Tomoyuki, Iwasaki, Norimasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384154/ https://www.ncbi.nlm.nih.gov/pubmed/28388910 http://dx.doi.org/10.1186/s12891-017-1509-1

Ejemplares similares

Impact of spino-pelvic and global spinal alignment on the risk of osteoporotic vertebral collapse
por: Ohnishi, Takashi, et al.
Publicado: (2018)

The efficacy of osteoporotic treatment in patients with new spinal vertebral compression fracture pain, ADL, QOL, bone metabolism and fracture-healing - In comparison with weekly teriparatide with bisphosphonate
por: Shigenobu, Keiichi, et al.
Publicado: (2019)

Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis
por: Satterwhite, Julie, et al.
Publicado: (2010)

Overexpression of Recombinant Human Teriparatide, rhPTH (1–34) in Escherichia coli : An Innovative Gene Fusion Approach
por: Bakhtiari, Nahid, et al.
Publicado: (2017)

The Application of Vertebral Augmentation Procedures and Teriparatide in the Treatment of Osteoporotic Vertebral Compression Fractures [Response to Letter]
por: Kong, Meng, et al.
Publicado: (2020)

Analysis of radiologic and clinical outcome in acute osteoporotic vertebral compression fracture: Single-agent teriparatide vs. teriparatide with subsequent vertebroplasty()
por: Jin, Yongjun
Publicado: (2023)

Could Teriparatide Replace Percutaneous Vertebral Augmentation for Patients with Osteoporotic Vertebral Compression Fracture to Some Extent? [Letter]
por: Zhou, Jiaming, et al.
Publicado: (2019)

Effects of teriparatide on lung function and pain relief in women with multiple osteoporotic vertebral compression fractures
por: Chen, Chien-Min, et al.
Publicado: (2014)

Can Three Months of Teriparatide Be One of Treatment Options for Osteoporotic Vertebral Compression Fracture Patients?
por: Kang, Jung Hoon, et al.
Publicado: (2019)

Effect of Teriparatide on Subsequent Vertebral Fractures after Instrumented Fusion Surgery for Osteoporotic Vertebral Fractures with Neurological Deficits
por: Maruo, Keishi, et al.
Publicado: (2019)

Potential effects of teriparatide (PTH (1–34)) on osteoarthritis: a systematic review
por: Li, Guoqing, et al.
Publicado: (2023)

Effect of bisphosphonates or teriparatide on mechanical complications after posterior instrumented fusion for osteoporotic vertebral fracture: a multi-center retrospective study
por: Kawabata, Atsuyuki, et al.
Publicado: (2020)

Nonsurgical Corrective Union of Osteoporotic Vertebral Fracture with Once-Weekly Teriparatide
por: Miyakoshi, Naohisa, et al.
Publicado: (2015)

Continuous rhPTH (1–34) treatment in chronic hypoparathyroidism
por: Fuss, Carmina Teresa, et al.
Publicado: (2020)

PTH 1-34 (teriparatide) may not improve healing in proximal humerus fractures: A randomized, controlled study of 40 patients
por: Johansson, Torsten
Publicado: (2016)

At Least One Cyclic Teriparatide Administration Can Be Helpful to Delay Initial Onset of a New Osteoporotic Vertebral Compression Fracture
por: Suk, Kyung Soo, et al.
Publicado: (2014)

Effects of Weekly Teriparatide Administration for Vertebral Stability and Bony Union in Patients with Acute Osteoporotic Vertebral Fractures
por: Kitaguchi, Kazuma, et al.
Publicado: (2019)

Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment
por: Yeh, Wen-Ling, et al.
Publicado: (2017)

Perioperative Complications of Open Spine Surgery in Older Adults over 90 Years of Age
por: Tsujimoto, Takeru, et al.
Publicado: (2022)

Teriparatide and vertebral fracture healing in Ankylosing Spondylitis
por: Biro, Izolda, et al.
Publicado: (2017)

Bone histomorphometry after treatment with teriparatide (PTH 1-34) in a patient with adynamic bone disease subsequent to parathyroidectomy
por: Lehmann, Gabriele, et al.
Publicado: (2009)

Clinical Outcomes and Postoperative Radiographic Assessment of Osteoplastic Hemilaminectomy in the Treatment of Lumbar Foraminal Nerve Root Compression
por: Tanaka, Masaru, et al.
Publicado: (2021)

Advances in Vertebral Augmentation Systems for Osteoporotic Vertebral Compression Fractures
por: Long, Yufeng, et al.
Publicado: (2020)

Continuous infusion of PTH(1–34) delayed fracture healing in mice
por: Yukata, Kiminori, et al.
Publicado: (2018)

Effect of an intensive conservative therapy with daily teriparatide administration and rehabilitation for osteoporotic delayed vertebral collapse and paralysis
por: Wakao, Norimitsu, et al.
Publicado: (2018)

Recombinant PTH: A Study of the Outcome of Teriparatide Therapy for 138 Patients with Osteoporosis
por: McNeilly, Thomas, et al.
Publicado: (2013)

Early Effects of Single and Low-Frequency Repeated Administration of Teriparatide, hPTH(1-34), on Bone Formation and Resorption in Ovariectomized Rats
por: Isogai, Yukihiro, et al.
Publicado: (2015)

12-Month Teriparatide Treatment Reduces New Vertebral Compression Fractures Incidence And Back Pain And Improves Quality Of Life After Percutaneous Kyphoplasty In Osteoporotic Women
por: Kong, Meng, et al.
Publicado: (2019)

Efficacy of Percutaneous Vertebroplasty in the Treatment of Osteoporotic Vertebral Compression Fractures with Intravertebral Cleft
por: Nakamae, Toshio, et al.
Publicado: (2015)

Radiological Factors Associated with Bisphosphonate Treatment Failure and Their Impact on Fracture Healing in Postmenopausal Women with Osteoporotic Vertebral Fractures
por: Kim, Hong Jin, et al.
Publicado: (2023)

Real-world persistence of twice-weekly teriparatide and factors associated with the discontinuation in patients with osteoporosis
por: Fujita, Ryo, et al.
Publicado: (2022)

Endogenous PTH Deficiency Impairs Fracture Healing and Impedes the Fracture-Healing Efficacy of Exogenous PTH(1-34)
por: Ren, Yongxin, et al.
Publicado: (2011)

Quality of Life in Patients with Osteoporotic Vertebral Compression Fractures
por: Jung, Ho Jin, et al.
Publicado: (2017)

Open Surgical Treatments of Osteoporotic Vertebral Compression Fractures
por: Li, Junyu, et al.
Publicado: (2023)

Graphene Oxide/RhPTH(1-34)/Polylactide Composite Nanofibrous Scaffold for Bone Tissue Engineering
por: Fei, Fan, et al.
Publicado: (2023)

Current Role and Application of Teriparatide in Fracture Healing of Osteoporotic Patients: A Systematic Review
por: Kim, Sang-Min, et al.
Publicado: (2017)

Teriparatide Improves Fracture Healing and Early Functional Recovery in Treatment of Osteoporotic Intertrochanteric Fractures
por: Huang, Tsan-Wen, et al.
Publicado: (2016)

Percutaneous vertebral augmentation in special Genant IV osteoporotic vertebral compression fractures
por: Pan, Mingming, et al.
Publicado: (2019)

High dose teriparatide (rPTH(1-34)) therapy increases callus volume and enhances radiographic healing at 8-weeks in a massive canine femoral allograft model
por: Nishitani, Kohei, et al.
Publicado: (2017)

Changes in serum vitamin D and PTH values using denosumab with or without bisphosphonate pre-treatment in osteoporotic patients: a short-term study
por: Nakamura, Yukio, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_14i1f0log8494k6hubseshvbg3